Digipath Announces Record Earnings of $292,533 for Recent Quarter Ended June 30
August 29, 2023
Digipath Enters Into Validation Agreement with CASPR Technologies to Determine Efficacy for New Anti-Microbial Product for the Cannabis Industry
March 1, 2022
Related Post
-
-
Digipath, Inc. Signs Agreement to Sell the Assets of Its Lab Subsidiary
May 5, 2023
-
Digipath, Inc. Announces Revenue Increase of Almost 18% for the Fourth Quarter of Fiscal Year 2022
December 8, 2022
-
Digipath Validates and Receives Approval to Use Free DNA Removal to Test for Aspergillus
May 2, 2022